http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2016383531-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fab5a78161702097f97524ce6e5cdcd7 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-154 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6858 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate | 2016-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af8966918fb06d2e1d7812193d7b6ac2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f20b6a7bc82b85162aa74c1f3e42a62c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cde91008ee51dc9ecc877e6b035a558b |
publicationDate | 2018-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2016383531-A1 |
titleOfInvention | Method and means for diagnosing tumors |
abstract | The invention relates to a method and means for diagnosing tumors, in particular for an early diagnosis (prevention) and for differentiating between benign and malignant tumors using a PCR, in particular in bodily fluids. The method according to the invention is characterized by a combination of a pre-amplification process using a PCR, wherein methylated DNA sequences are amplified more strongly than non-methylated DNA sequences, and a subsequent quantification process using a special digital PCR, in which significantly more DNA is used than normally in the prior art. As comparison data indicates, the invention advantageously allows a clear reliable conclusion as to whether a malignant tumor disease is present or not. The invention is suitable for screening (prevention), monitoring the progress of a tumor disease, in particular in order to exclude a minimal residual disease (MRD), and for a differential diagnosis between malignant carcinoma and benign tumors. |
priorityDate | 2015-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 170.